Dr. Ryan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Yaw 7e
Boston, MA 02114Phone+1 617-724-0245Fax+1 617-724-3166
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1992 - 1996
Columbia University Vagelos College of Physicians and SurgeonsClass of 1992
Certifications & Licensure
MA State Medical License 1996 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- Boston Magazine Castle Connolly, 2010-2013
- America's Top Doctors for Cancer Castle Connolly, 2010-2013
Clinical Trials
- Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum Start of enrollment: 2000 Jul 01
- Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer Start of enrollment: 2004 Jul 01
- Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer Start of enrollment: 2005 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 138 citationsMolecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric CancerEunice L. Kwak, Leanne G. Ahronian, Giulia Siravegna, Benedetta Mussolin, Jason T. Godfrey
Cancer Discovery. 2015-10-02 - 204 citationsNeoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical TrialCarmen J. Allegra, Greg Yothers, Michael O’Connell, Robert W. Beart, Timothy F. Wozniak
Journal of the National Cancer Institute. 2015-11-01 - 294 citationsCapecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project...Michael J. O'Connell, Linda H. Colangelo, Robert W. Beart, N. J. Petrelli, Carmen J. Allegra
Journal of Clinical Oncology. 2014-06-20
Lectures
- Optimizing Locoregional Management in the Context of Multidisciplinary CareASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
Other
- Clinical features, staging, and treatment of anal cancerRyan DP, Willett CG
http://www.uptodate.com/contents/clinical-features-staging-and-treatment-of-anal-cancer
UpToDate, Wolters Kluwer Health - 2013-03-26 - Ampullary carcinoma: Treatment and prognosisRyan DP, Castillo CF, Mamon H
http://www.uptodate.com/contents/ampullary-carcinoma-treatment-and-prognosis
UpToDate, Wolters Kluwer Health - 2012-07-19 - Classification and epidemiology of anal cancerRyan DP, Willett CG
http://www.uptodate.com/contents/classification-and-epidemiology-of-anal-cancer
UpToDate, Wolters Kluwer Health - 2012-12-20 - Join now to see all
Press Mentions
Dana-Farber, Brigham Split Creates New Opportunities for Cancer CareNovember 1st, 2024- $1 Million Gift to Mass General Cancer Center Will Support Promising Research Conducted by Pioneering Physician-ScientistsOctober 21st, 2024
- Cullinan Oncology Announces the Appointment of David P. Ryan, M.D. To Its Board of DirectorsNovember 2nd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
